All updated as on -
The market for cloning and mutagenesis was assessed at $3.10 billion in 2023 and is anticipated to expand at a CAGR of 19.7% over the next five years.
The usage of cloning and mutagenesis technologies, including PCR, which is projected to increase soon due to the rising need for personalized treatment, is responsible for the market's optimistic growth potential. Chronic diseases and genetic anomalies are becoming more commonplace on a global scale. The market's growth prospects are improving as protein engineering for medicinal development get more attention. Cloning and mutagenesis are two essential methods utilized in protein engineering while creating new medications.
Cloning is the process of producing naturally occurring or purposefully produced, genetically identical copies of an organism. Mutagenesis is the process through which an organism's genetic makeup is altered, leading to a mutation. In a laboratory context, mutagenesis is carried out when DNA is purposefully modified to produce mutant proteins, genes, or strains of an organism. Cloning and mutagenesis are two of the most effective methods created to research the links between protein structure and function. They are used to confirm the effects of mutations both in vitro and in vivo. Due to the growing use of cloning in numerous genetic applications, such as reproductive cloning, the global cloning and mutagenesis industry is expected to rise.
The global market for cloning and mutagenesis had a substantial valuation of USD 2.30 billion as of 2022. This market includes the creation and sale of equipment and know-how for cloning and mutagenesis procedures for genetic engineering and research. While mutagenesis refers to the purposeful altering of genes to research their function or produce desired genetic alterations, cloning entails the reproduction of specific DNA sequences. The market's growth has been fueled by the rising need for genetic research and personalized treatment. The development of gene editing technologies like CRISPR and improvements in molecular biology methods have both sped up this process. The cloning and mutagenesis market is anticipated to continue growing in the near future due to ongoing developments and applications in numerous scientific fields.
Cloning and mutagenesis products have been used more frequently during the past two years as a result of the COVID-19 outbreak. By implementing revolutionary strategies for creating medicines, kits, and vaccines for COVID-19, a number of significant biotechnology and pharmaceutical businesses, as well as makers of cloning and mutagenesis kit products, have increased their R&D operations globally. For instance, CanSino Biologics Inc. was granted permission by China's National Medical Products Administration to utilize an inhalable form of the adenovirus-vectored COVID-19 vaccine for emergency purposes in September 2022. It is created by cloning the full-length gene for the S protein combined with an optimized plasminogen activator signal peptide gene in the Ad5 vector.
Due of the growing acceptance of reproductive cloning, it is projected that the cloning and mutagenesis markets would grow significantly during the forecast period. Additionally, the industry's frequent product introductions and advancements support market growth. The growing use of tailored medications and the increase in diseases are also projected to support the expansion of the global market. The market demand is driven by the increasing prevalence of diseases like cancer and HIV as well as the rising investment in research into genetic diseases. Future growth of the biotechnology sector is being aided by the industry's expansion and growing government initiatives, such as sponsoring medical research.
The market's growth prospects are also becoming more promising as protein engineering for medicinal development receives more attention. Cloning and mutagenesis are two essential methods utilized in protein engineering while creating new medications. By permitting the insertion, deletion, or substitution of nucleotides in protein sequences, these techniques aid in the synthesis of therapeutic proteins.
Report Coverage
Global Cloning & Mutagenesis research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cloning & Mutagenesis report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cloning & Mutagenesis competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cloning & Mutagenesis market players and analyses their core competencies in each global market sub-segments.
Key Points Covered in the Report
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cloning & Mutagenesis market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cloning & Mutagenesis market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd., Genomax Technologies Pte Ltd., abm Inc., GenScript, EZBioscience, and others.
Primary Target Market
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cloning & Mutagenesis market based on the below-mentioned segments:
Global Cloning & Mutagenesis Market, By Product
Cloning Kits
Mutagenesis Kits
Global Cloning & Mutagenesis market, By Technology
TOPO PCR Cloning
Site-directed Mutagenesis
Global Cloning & Mutagenesis Market, By End User
Biopharmaceuticals and pharmaceutical companies
CROs and CMOs
Global Cloning & Mutagenesis market, Regional Analysis
The usage of cloning and mutagenesis technologies, including PCR, which is projected to increase soon due to the rising need for personalized treatment, is responsible for the market's optimistic growth potential. Chronic diseases and genetic anomalies are becoming more commonplace on a global scale. The market's growth prospects are improving as protein engineering for medicinal development get more attention. Cloning and mutagenesis are two essential methods utilized in protein engineering while creating new medications.
Cloning is the process of producing naturally occurring or purposefully produced, genetically identical copies of an organism. Mutagenesis is the process through which an organism's genetic makeup is altered, leading to a mutation. In a laboratory context, mutagenesis is carried out when DNA is purposefully modified to produce mutant proteins, genes, or strains of an organism. Cloning and mutagenesis are two of the most effective methods created to research the links between protein structure and function. They are used to confirm the effects of mutations both in vitro and in vivo. Due to the growing use of cloning in numerous genetic applications, such as reproductive cloning, the global cloning and mutagenesis industry is expected to rise.
The global market for cloning and mutagenesis had a substantial valuation of USD 2.30 billion as of 2022. This market includes the creation and sale of equipment and know-how for cloning and mutagenesis procedures for genetic engineering and research. While mutagenesis refers to the purposeful altering of genes to research their function or produce desired genetic alterations, cloning entails the reproduction of specific DNA sequences. The market's growth has been fueled by the rising need for genetic research and personalized treatment. The development of gene editing technologies like CRISPR and improvements in molecular biology methods have both sped up this process. The cloning and mutagenesis market is anticipated to continue growing in the near future due to ongoing developments and applications in numerous scientific fields.
Cloning and mutagenesis products have been used more frequently during the past two years as a result of the COVID-19 outbreak. By implementing revolutionary strategies for creating medicines, kits, and vaccines for COVID-19, a number of significant biotechnology and pharmaceutical businesses, as well as makers of cloning and mutagenesis kit products, have increased their R&D operations globally. For instance, CanSino Biologics Inc. was granted permission by China's National Medical Products Administration to utilize an inhalable form of the adenovirus-vectored COVID-19 vaccine for emergency purposes in September 2022. It is created by cloning the full-length gene for the S protein combined with an optimized plasminogen activator signal peptide gene in the Ad5 vector.
Due of the growing acceptance of reproductive cloning, it is projected that the cloning and mutagenesis markets would grow significantly during the forecast period. Additionally, the industry's frequent product introductions and advancements support market growth. The growing use of tailored medications and the increase in diseases are also projected to support the expansion of the global market. The market demand is driven by the increasing prevalence of diseases like cancer and HIV as well as the rising investment in research into genetic diseases. Future growth of the biotechnology sector is being aided by the industry's expansion and growing government initiatives, such as sponsoring medical research.
The market's growth prospects are also becoming more promising as protein engineering for medicinal development receives more attention. Cloning and mutagenesis are two essential methods utilized in protein engineering while creating new medications. By permitting the insertion, deletion, or substitution of nucleotides in protein sequences, these techniques aid in the synthesis of therapeutic proteins.
Report Coverage
Global Cloning & Mutagenesis research report categorizes the market for global based on various segments and regions, forecasts revenue growth, and analyzes trends in each submarket. Global Cloning & Mutagenesis report analyses the key growth drivers, opportunities, and challenges influencing the global market. Recent market developments and Cloning & Mutagenesis competitive strategies such as expansion, product launch and development, partnership, merger, and acquisition have been included to draw the competitive landscape in the market. The report strategically identifies and profiles the key Cloning & Mutagenesis market players and analyses their core competencies in each global market sub-segments.
| REPORT ATTRIBUTES | DETAILS |
|---|---|
| Study Period | 2017-2030 |
| Base Year | 2022 |
| Forecast Period | 2022-2030 |
| Historical Period | 2017-2021 |
| Unit | Value (USD Billion) |
| Key Companies Profiled | Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd., Genomax Technologies Pte Ltd., abm Inc., GenScript, EZBioscience, and others. |
| Segments Covered | • By Product |
| Customization Scope | Free report customization (equivalent to up to 3 analyst working days) with purchase. Addition or alteration to country, regional & segment scope |
Key Points Covered in the Report
- Market Revenue of Cloning & Mutagenesis Market from 2021 to 2030.
- Market Forecast for Cloning & Mutagenesis Market from 2021 to 2030.
- Regional Market Share and Revenue from 2021 to 2030.
- Country Market share within region from 2021 to 2030.
- Key Type and Application Revenue and forecast.
- Company Market Share Analysis, Cloning & Mutagenesis competitive scenario, ranking, and detailed company
profiles. - Market driver, restraints, and detailed COVID-19 impact on Cloning & Mutagenesis
Market
Competitive Environment:
The research provides an accurate study of the major organisations and companies operating in the global Cloning & Mutagenesis market, along with a comparative evaluation based on their product portfolios, corporate summaries, geographic reach, business plans, Cloning & Mutagenesis market shares in specific segments, and SWOT analyses. A detailed analysis of the firms' recent news and developments, such as product development, inventions, joint ventures, partnerships, mergers and acquisitions, strategic alliances, and other activities, is also included in the study. This makes it possible to assess the level of market competition as a whole.
List of Major Market Participants
Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., New England Biolabs, Takara Bio Inc., Merck KGaA, Promega Corporation, Bio-Rad Laboratories, Inc., Danaher, Jena Bioscience GmbH, Assay Genie, TransGen Biotech Co., Ltd., Genomax Technologies Pte Ltd., abm Inc., GenScript, EZBioscience, and others.
Primary Target Market
- Market Players of Cloning & Mutagenesis
- Investors
- End-users
- Government Authorities
- Consulting And Research Firm
- Venture capitalists
- Third-party knowledge providers
- Value-Added Resellers (VARs)
Market Segment:
This study forecasts global, regional, and country revenue from 2019 to 2030. INFINITIVE DATA EXPERT has segmented the global Cloning & Mutagenesis market based on the below-mentioned segments:
Global Cloning & Mutagenesis Market, By Product
Cloning Kits
Mutagenesis Kits
Global Cloning & Mutagenesis market, By Technology
TOPO PCR Cloning
Site-directed Mutagenesis
Global Cloning & Mutagenesis Market, By End User
Biopharmaceuticals and pharmaceutical companies
CROs and CMOs
Global Cloning & Mutagenesis market, Regional Analysis
- Europe: Germany, Uk, France, Italy, Spain, Russia, Rest of Europe
- The Asia Pacific: China,Japan,India,South Korea,Australia,Rest of Asia Pacific
- South America: Brazil, Argentina, Rest of South America
- Middle East & Africa: UAE, Saudi Arabia, Qatar, South Africa, Rest of Middle East & Africa
About This Research
You will get in-depth and extensive cloning mutagenesis market market research and competitor analysis for your business to help you develop more profound insights into the cloning mutagenesis market Market.
Through INFINITIVE Data Expert is a professional Market Research services, I will identify the cloning mutagenesis market market size, demand & opportunities, growth rate, and target audience with a comprehensive analysis of your competitors.